Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial (Q40775150)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial |
scientific article |
Statements
1 reference
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial (English)
1 reference
Emmanuelle Le Page
1 reference
David Veillard
1 reference
David A Laplaud
1 reference
Stéphanie Hamonic
1 reference
Rasha Wardi
1 reference
Christine Lebrun
1 reference
Fabien Zagnoli
1 reference
Sandrine Wiertlewski
1 reference
Véronique Deburghgraeve
1 reference
Marc Coustans
1 reference
Gilles Edan
1 reference
COPOUSEP investigators
1 reference
West Network for Excellence in Neuroscience
1 reference
26 June 2015
1 reference
1 reference
Identifiers
1 reference